This inventor holds 2 USPTO granted patents. Top assignees: Unversität Zürich, Other. Active years: 2003-2017.
Location History:
- Wald, CH (2003)
- Trüllikon, CH (2017)
Company Filing History:
1 out of 276 
1 out of 834,453 Years Active: 2003-2017
Title: Cornel Fraefel: Innovator in Therapeutic Solutions
Introduction
Cornel Fraefel is a notable inventor based in Trüllikon, Switzerland. He has made significant contributions to the field of medical therapies, particularly in the treatment of multiple sclerosis. With a focus on innovative solutions, Fraefel holds 2 patents that showcase his expertise and dedication to advancing healthcare.
Latest Patents
Fraefel's latest patents include groundbreaking inventions aimed at improving therapeutic approaches. One of his notable patents is titled "APC-mediated tolerance induction for therapy of multiple sclerosis." This invention involves transgene expression constructs, specifically self-inactivating lentiviral vectors, which utilize a dendritic cell-specific promoter to control the expression of autoantigen proteins. These proteins include myelin basic protein, proteolipid protein, and myelin oligodendrocyte glycoprotein, all of which are crucial for the therapy of multiple sclerosis.
Another significant patent is "Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors." This invention presents an enhanced and simplified packaging system for herpes virus amplicons. The system comprises a herpes virus amplicon vector and a packaging vector, which includes a bacterial artificial chromosome containing the HSV-1 genome. This innovative approach allows for the packaging of a wide range of nucleotide sequences into an empty herpes virus particle, providing a versatile platform for therapeutic applications.
Career Highlights
Throughout his career, Cornel Fraefel has worked with prestigious institutions, including Universität Zürich. His work has significantly impacted the field of virology and therapeutic development, showcasing his commitment to advancing medical science.
Collaborations
Fraefel has collaborated with esteemed colleagues such as Mathias Ackermann and Yoshinaga Saeki. These partnerships have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Cornel Fraefel stands out as a prominent inventor in the realm of therapeutic innovations. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions. Through his work, he continues to make a meaningful impact on the field of medicine.